Add Company
Join Now

Cygnal Therapeutics Revenue and Competitors

License our Company Data API

Boston, MA USA

Location

$65M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Cygnal Therapeutics's estimated annual revenue is currently $1.2M per year.(i)
  • Cygnal Therapeutics's estimated revenue per employee is $77,500
  • Cygnal Therapeutics's total funding is $65M.

Employee Data

  • Cygnal Therapeutics has 16 Employees.(i)
  • Cygnal Therapeutics grew their employee count by -11% last year.

Cygnal Therapeutics's People

NameTitleEmail/Phone
1
SVP, IP & Legal AffairsReveal Email/Phone
2
Senior Researcher Associate at TherapeuticsReveal Email/Phone
3
Co-op Research AssociateReveal Email/Phone
4
Senior Research AssociateReveal Email/Phone
5
Senior Scientist, immuno-oncologyReveal Email/Phone
6
Senior ScientistReveal Email/Phone
7
Research AssistantReveal Email/Phone
8
Research AssistantReveal Email/Phone
9
ScientistReveal Email/Phone
10
Senior Research AssociateReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Cygnal Therapeutics?

Founded in 2017 by Flagship Pioneering, Cygnal Therapeutics is the first company to build a platform to develop drugs in the field of exoneural biology. Exoneural biology is broadly implicated in human health and disease. Fueled by our dynamic Exoneural Medicine Platformￃﾢ￢ﾀﾞￂﾢ, we are creating new medicines across multiple therapeutic areas, starting with cancer and inflammatory diseases.

keywords:N/A

$65M

Total Funding

16

Number of Employees

$1.2M

Revenue (est)

-11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.8M16-6%N/A
#2
$2.5M167%N/A
#3
$1.2M16-6%$59M
#4
$1.9M160%N/A
#5
$1.7M167%N/A